lipoxin a4 has been researched along with u 0126 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ariel, A; Arita, M; Chiang, N; Petasis, NA; Serhan, CN | 1 |
1 other study(ies) available for lipoxin a4 and u 0126
Article | Year |
---|---|
Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Butadienes; CD3 Complex; Cell Separation; Enzyme Activation; Humans; Hydroxyeicosatetraenoic Acids; Immune Sera; Immunosuppressive Agents; Jurkat Cells; Leukocytes, Mononuclear; Lipoxins; Lymphocyte Activation; Mitogen-Activated Protein Kinases; Nitriles; Receptors, Cell Surface; Receptors, Formyl Peptide; Receptors, Lipoxin; T-Lymphocytes; Transfection; Tumor Necrosis Factor-alpha | 2003 |